Cargando…

Influence of smoking on levels of urinary 8-iso Prostaglandin F2α

BACKGROUND: To evaluate the reduced-risk potential of alternative tobacco products, biomarkers that are involved in the biological pathways affected by cigarette smoking and smoking cessation are needed. Isoprostanes, a measure of oxidative stress, appear to be influenced by smoking and reversible u...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Plas, Angela, Pouly, Sandrine, de La Bourdonnaye, Guillaume, Baker, Gizelle, Lüdicke, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260378/
https://www.ncbi.nlm.nih.gov/pubmed/30519530
http://dx.doi.org/10.1016/j.toxrep.2018.11.011
_version_ 1783374779312504832
author van der Plas, Angela
Pouly, Sandrine
de La Bourdonnaye, Guillaume
Baker, Gizelle
Lüdicke, Frank
author_facet van der Plas, Angela
Pouly, Sandrine
de La Bourdonnaye, Guillaume
Baker, Gizelle
Lüdicke, Frank
author_sort van der Plas, Angela
collection PubMed
description BACKGROUND: To evaluate the reduced-risk potential of alternative tobacco products, biomarkers that are involved in the biological pathways affected by cigarette smoking and smoking cessation are needed. Isoprostanes, a measure of oxidative stress, appear to be influenced by smoking and reversible upon smoking cessation and therefore could be a good biomarker. This review aims at quantifying the effect of smoking and smoking cessation on levels of urinary 8-iso prostaglandin F(2α) (8-epi-PGF(2α)), an isoprostane. METHODS: PubMed and Scopus databases were searched for publications that reported 8-epi-PGF(2α) levels in smokers and nonsmokers as well as articles reporting the effect of smoking cessation on 8-epi-PGF(2α) levels. RESULTS: Eighteen studies assessing 8-epi-PGF(2α) levels by smoking status were identified. Five of the papers reported the results as quantity excreted in 24-hour urine (μg/24 h), and 15 reported creatinine adjusted values. The meta-analyses show increased levels of 8-epi-PGF(2α) in current smokers compared with nonsmokers (mean difference = 0.16, 95% confidence interval [95%CI]: 0.14–0.19 μg/24 h with inconsistency statistic [I(2)] = 98%; mean difference = 172.38, 95%CI: 152.75–192.01 pg/mg creatinine with I(2) = 89%, respectively). There were too few publications to perform a meta-analysis assessing the effects of smoking cessation on 8-epi-PGF(2α) levels. CONCLUSIONS: Due to the high heterogeneity among the studies included in these meta-analyses, it is difficult to generalize the results; however, our study indicates increased levels of 8-epi-PGF(2α) and therefore increased oxidative stress in smokers compared with nonsmokers. More studies are still needed to assess if 8-epi-PGF(2α) levels are reversible after cessation.
format Online
Article
Text
id pubmed-6260378
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62603782018-12-05 Influence of smoking on levels of urinary 8-iso Prostaglandin F2α van der Plas, Angela Pouly, Sandrine de La Bourdonnaye, Guillaume Baker, Gizelle Lüdicke, Frank Toxicol Rep Article BACKGROUND: To evaluate the reduced-risk potential of alternative tobacco products, biomarkers that are involved in the biological pathways affected by cigarette smoking and smoking cessation are needed. Isoprostanes, a measure of oxidative stress, appear to be influenced by smoking and reversible upon smoking cessation and therefore could be a good biomarker. This review aims at quantifying the effect of smoking and smoking cessation on levels of urinary 8-iso prostaglandin F(2α) (8-epi-PGF(2α)), an isoprostane. METHODS: PubMed and Scopus databases were searched for publications that reported 8-epi-PGF(2α) levels in smokers and nonsmokers as well as articles reporting the effect of smoking cessation on 8-epi-PGF(2α) levels. RESULTS: Eighteen studies assessing 8-epi-PGF(2α) levels by smoking status were identified. Five of the papers reported the results as quantity excreted in 24-hour urine (μg/24 h), and 15 reported creatinine adjusted values. The meta-analyses show increased levels of 8-epi-PGF(2α) in current smokers compared with nonsmokers (mean difference = 0.16, 95% confidence interval [95%CI]: 0.14–0.19 μg/24 h with inconsistency statistic [I(2)] = 98%; mean difference = 172.38, 95%CI: 152.75–192.01 pg/mg creatinine with I(2) = 89%, respectively). There were too few publications to perform a meta-analysis assessing the effects of smoking cessation on 8-epi-PGF(2α) levels. CONCLUSIONS: Due to the high heterogeneity among the studies included in these meta-analyses, it is difficult to generalize the results; however, our study indicates increased levels of 8-epi-PGF(2α) and therefore increased oxidative stress in smokers compared with nonsmokers. More studies are still needed to assess if 8-epi-PGF(2α) levels are reversible after cessation. Elsevier 2018-11-20 /pmc/articles/PMC6260378/ /pubmed/30519530 http://dx.doi.org/10.1016/j.toxrep.2018.11.011 Text en © 2018 The Authors. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
van der Plas, Angela
Pouly, Sandrine
de La Bourdonnaye, Guillaume
Baker, Gizelle
Lüdicke, Frank
Influence of smoking on levels of urinary 8-iso Prostaglandin F2α
title Influence of smoking on levels of urinary 8-iso Prostaglandin F2α
title_full Influence of smoking on levels of urinary 8-iso Prostaglandin F2α
title_fullStr Influence of smoking on levels of urinary 8-iso Prostaglandin F2α
title_full_unstemmed Influence of smoking on levels of urinary 8-iso Prostaglandin F2α
title_short Influence of smoking on levels of urinary 8-iso Prostaglandin F2α
title_sort influence of smoking on levels of urinary 8-iso prostaglandin f2α
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260378/
https://www.ncbi.nlm.nih.gov/pubmed/30519530
http://dx.doi.org/10.1016/j.toxrep.2018.11.011
work_keys_str_mv AT vanderplasangela influenceofsmokingonlevelsofurinary8isoprostaglandinf2a
AT poulysandrine influenceofsmokingonlevelsofurinary8isoprostaglandinf2a
AT delabourdonnayeguillaume influenceofsmokingonlevelsofurinary8isoprostaglandinf2a
AT bakergizelle influenceofsmokingonlevelsofurinary8isoprostaglandinf2a
AT ludickefrank influenceofsmokingonlevelsofurinary8isoprostaglandinf2a